Author

Elayaraja Kolanthai

University of Central FloridaORCID 0000-0003-2615-6866Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Assay:protein structure· 2 Research Focus:benchmarking· 1 Research Focus:protein design· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Aida Tayebi· 2 shared Craig J. NealiD· 2 shared Mehdi Yazdani-JahromiiD· 2 shared Niloofar YousefiiD· 2 shared Özlem Özmen GaribayiD· 2 shared Sudipta SealiD· 2 shared Agnivo GosaiiD· 1 shared Ganesh BalasubramanianiD· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Aida Tayebi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsBriefings in BioinformaticsPeer-reviewedApr 24, 2023

BindingSiteAugmentedDTA: Enabling A Next-Generation Pipeline for Interpretable Prediction Models in Drug-Repurposing

Niloofar Yousefi, Mehdi Yazdani-Jahromi, Aida Tayebi…·Özlem Özmen Garibay

This paper introduces a deep learning framework for drug-target interaction prediction that improves accuracy and interpretability by incorporating binding site information and validates it through experimental testing.

28 citationstop 5%

protein structuredeep learning

𝕏 PostBluesky

BioinformaticsBriefings in BioinformaticsPeer-reviewedJul 11, 2022

Interpretable and Generalizable Attention-Based Model for Predicting Drug-Target Interaction Using 3D Structure of Protein Binding Sites: SARS-CoV-2 Case Study and in-Lab Validation

Mehdi Yazdani-Jahromi, Niloofar Yousefi, Aida Tayebi…·Özlem Özmen Garibay

This paper introduces an interpretable graph-based deep learning model for predicting drug-target interactions using protein binding sites, validated with experimental testing on SARS-CoV-2 targets.

125 citationstop 1%

protein structuredeep learning

𝕏 PostBluesky